Further, overexpression of BCL-2 or BCL-XL in these mice [17], [18] or in transplanted bone marrow cells [11], [19] accelerates MYC-driven tumor development, suggesting that BCL-2 and BCL-XL act in synergy with MYC in tumorigenesis. Here, MYC is linked to neoplasm.